1 |
Novartis, et al v. Abbott Laboratories |
1:00-cv-00784 |
D.Del. |
|
|
|
|
2 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
3 |
Novartis AG et al v. Apotex Inc. et al |
1:05-cv-03855 |
S.D.N.Y. |
|
|
|
|
4 |
CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. |
3:06-cv-06154 |
D.N.J. |
|
|
|
|
5 |
CELGENE CORPORATION et al v. ABRIKA PHARMACEUTICALS, INC. et al |
3:06-cv-05818 |
D.N.J. |
|
|
|
|
6 |
CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. |
3:04-cv-04030 |
D.N.J. |
|
|
|
|
7 |
Novartis Phar Corp, et al v. Sun Pharm Ind Ltd |
1:04-cv-05477 |
N.D.Ill. |
|
|
|
|
8 |
CELGENE CORPORATION et al v. KV PHARMACEUTICAL COMPANY |
3:07-cv-04819 |
D.N.J. |
|
|
|
|
9 |
CELGENE CORPORATION et al v. TEVA PHARMACEUTICALS USA, INC. |
3:07-cv-04459 |
D.N.J. |
|
|
|
|
10 |
Novartis Pharmaceuticals Corporation et al v. Apotex Corp. et al |
1:10-cv-00916 |
D.Del. |
|
|
|
|
11 |
CELGENE CORPORATION et al V. ACTAVIS SOUTH ATLANTIC LLC |
2:11-cv-02162 |
D.N.J. |
|
|
|
|
12 |
CELGENE CORPORATION et al V. TEVA PHARMACEUTICALS USA, INC. |
2:11-cv-02356 |
D.N.J. |
|
|
|
|
13 |
Eisai Co. Ltd. et al. v. Lupin Ltd., et al. |
1:13-cv-01281 |
D.Del. |
|
|
|
|
14 |
Eisai Co. Ltd. et al v. Roxane Laboratories Inc. |
1:14-cv-01511 |
D.Del. |
|
|
|
|
15 |
Actavis Elizabeth LLC v. Novartis Corporation et al |
1:16-cv-00604 |
D.Del. |
|
|
|
|
16 |
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals USA, Inc. |
1:16-cv-00648 |
D.Del. |
|
|
|
|
17 |
Eisai Co., Ltd. et al v. Bionpharma Inc. |
1:18-cv-00618 |
D.Del. |
|
|
|
|